reviewCancer CellAug 17, 2023GREEN OA

Neoadjuvant immune checkpoint blockade: A window of opportunity to advance cancer immunotherapy

SLSuzanne L. Topalian PMPatrick M. Forde LALeisha A. Emens MYMark Yarchoan KNKellie N. Smith

Bloomberg (United States) · Johns Hopkins University · +3 more institutions

Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

268

total citations

FWCI: 58.45
Percentile: 100%
References: 113

Citations per year

Authors

6

SL
Suzanne L. TopalianCorresponding
Bloomberg (United States), Johns Hopkins University, Johns Hopkins Medicine, Sidney Kimmel Comprehensive Cancer Center
PM
Patrick M. Forde
Bloomberg (United States), Johns Hopkins University, Johns Hopkins Medicine, Sidney Kimmel Comprehensive Cancer Center
LA
Leisha A. Emens
Akebia Therapeutics (United States)
MY
Mark Yarchoan
Bloomberg (United States), Johns Hopkins University, Johns Hopkins Medicine, Sidney Kimmel Comprehensive Cancer Center
KN
Kellie N. Smith
Bloomberg (United States), Johns Hopkins University, Johns Hopkins Medicine, Sidney Kimmel Comprehensive Cancer Center

Topics & keywords

Topics

Keywords

Blockade
Immune checkpoint
Window of opportunity
Immunotherapy
Cancer immunotherapy
Cancer
Medicine
Therapeutic window

UN Sustainable Development Goals

Good health and well-being

No related works found for this paper.